EU Approves First New Lung Fibrosis Drug in 10 Years

More than 500,000 Europeans living with deadly lung scarring diseases just got their first new treatment option in over a decade.

The oral medication slows lung function decline and doesn't require the burdensome liver monitoring older treatments demand.